ARCHIVES

Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

Most Comprehensive Centers Score High; Few May Be In Trouble; Directors Back Program

May 19, 1978

NIH Changes SBIR/STTG Application Receipt Dates.

February 18, 2000

Cancer Advocates Seek 6.5% Increase For NCI In Fiscal 1997

March 8, 1996

Harvard’s DePinho Becomes Finalist at MD Anderson

May 20, 2011

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006

Funding Opportunities.

July 19, 2002